Compare APGE & ALK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | APGE | ALK |
|---|---|---|
| Founded | 2022 | 1932 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Air Freight/Delivery Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 5.1B |
| IPO Year | 2023 | 2003 |
| Metric | APGE | ALK |
|---|---|---|
| Price | $81.29 | $44.01 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 12 |
| Target Price | ★ $109.67 | $62.92 |
| AVG Volume (30 Days) | 751.1K | ★ 3.1M |
| Earning Date | 05-12-2026 | 04-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $10,426,000,000.00 |
| Revenue This Year | N/A | $11.19 |
| Revenue Next Year | N/A | $5.11 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 8.09 |
| 52 Week Low | $34.34 | $33.03 |
| 52 Week High | $95.32 | $65.35 |
| Indicator | APGE | ALK |
|---|---|---|
| Relative Strength Index (RSI) | 48.04 | 58.54 |
| Support Level | $80.52 | $36.64 |
| Resistance Level | $86.42 | $44.57 |
| Average True Range (ATR) | 4.40 | 1.73 |
| MACD | -0.17 | 0.83 |
| Stochastic Oscillator | 54.32 | 68.37 |
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
Alaska Air Group Inc operates two airlines, Alaska and Horizon, in three operating segments. The Alaska Airlines segment includes scheduled air transportation on Alaska's Boeing and Airbus jet aircraft for passengers and cargo throughout the U.S., and in parts of Mexico and Costa Rica. The Regional segment includes Horizon's and other third-party carriers' scheduled air transportation for passengers across a shorter distance network within the U.S. and Canada under capacity purchase agreements. The Hawaiian Airlines segment includes scheduled air transportation on Hawaiian's Boeing and Airbus aircraft for passengers and cargo. It earns revenues from Passenger tickets, including ticket breakage and net of taxes and fees, Passenger ancillary, and Mileage Plan passenger revenue.